Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,045 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community.
Mirza MA, Larsson A, Lind L, Larsson TE. Mirza MA, et al. Among authors: lind l. Atherosclerosis. 2009 Aug;205(2):385-90. doi: 10.1016/j.atherosclerosis.2009.01.001. Epub 2009 Jan 9. Atherosclerosis. 2009. PMID: 19181315
Serum urate and renal function in different forms of hypercalcemia.
Lind L, Ljunghall S. Lind L, et al. Exp Clin Endocrinol. 1992;99(2):87-90. doi: 10.1055/s-0029-1211142. Exp Clin Endocrinol. 1992. PMID: 1639124
When compared to normocalcemic control subjects (serum urate 336 +/- 110 mumol/l) both HPT subjects (356 +/- 98 mmol/1, p less than 0.006) and the cancer patients (407 +/- 179 mmol/l, p less than 0.001) showed raised levels of serum urate. ...Serum urea was not sign …
When compared to normocalcemic control subjects (serum urate 336 +/- 110 mumol/l) both HPT subjects (356 +/- 98 mmol/1, p less than 0 …
Hypertension in primary hyperparathyroidism in relation to histopathology.
Lind L, Hvarfner A, Palmér M, Grimelius L, Akerström G, Ljunghall S. Lind L, et al. Eur J Surg. 1991 Aug;157(8):457-9. Eur J Surg. 1991. PMID: 1681931
Potassium and blood pressure.
Lind L, Lithell H, Pollare T, Ljunghall S. Lind L, et al. Ups J Med Sci. 1991;96(1):69-74. doi: 10.3109/03009739109179260. Ups J Med Sci. 1991. PMID: 1897064
Reduction in serum alkaline phosphatase levels by treatment with active vitamin D (alphacalcidol) in primary and secondary hyperparathyroidism and in euparathyroid individuals.
Lind L, Wengle B, Lithell H, Ljunghall S. Lind L, et al. Scand J Urol Nephrol. 1991;25(3):233-6. doi: 10.3109/00365599109107953. Scand J Urol Nephrol. 1991. PMID: 1947853 Clinical Trial.
Oral alphacalcidol (1 microgram daily) significantly reduced serum ALP (3.2 +/- 1.1 to 2.8 +/- 1.2 mu kat/l, p less than 0.05) in a 6-month double-blind, placebo-controlled study in patients with mild primary HPT, and alphacalcidol given intravenously to uremic subjects in …
Oral alphacalcidol (1 microgram daily) significantly reduced serum ALP (3.2 +/- 1.1 to 2.8 +/- 1.2 mu kat/l, p less than 0.05) in a 6 …
Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases.
Lind L, Jacobsson S, Palmér M, Lithell H, Wengle B, Ljunghall S. Lind L, et al. J Intern Med. 1991 Jul;230(1):29-35. doi: 10.1111/j.1365-2796.1991.tb00403.x. J Intern Med. 1991. PMID: 2066709
Indices of mineral metabolism in subjects with an impaired glucose tolerance.
Lind L, Lithell H, Hvarfner A, Ljunghall S. Lind L, et al. Exp Clin Endocrinol. 1990 Sep;96(1):109-12. doi: 10.1055/s-0029-1210996. Exp Clin Endocrinol. 1990. PMID: 2279519
The IGT subjects showed higher levels of serum calcium (2.38 +/- 0.081 mmol/l (SD) vs 2.35 +/- 0.065 in controls) but similar levels of plasma ionized calcium indicating an increased protein binding of serum calcium in IGT. Serum magnesium was significantly lower in the IG …
The IGT subjects showed higher levels of serum calcium (2.38 +/- 0.081 mmol/l (SD) vs 2.35 +/- 0.065 in controls) but similar levels …
Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease.
Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S. Lind L, et al. BMJ. 1988 Oct 15;297(6654):960-3. doi: 10.1136/bmj.297.6654.960. BMJ. 1988. PMID: 3142567 Free PMC article.
A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure.
Lind L, Lithell H, Wengle B, Wrege U, Ljunghall S. Lind L, et al. Scand J Urol Nephrol. 1988;22(3):219-22. Scand J Urol Nephrol. 1988. PMID: 3187441
Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance--a prospective randomized double-blind study.
Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sørensen OH, Wide L. Ljunghall S, et al. Among authors: lind l. Acta Med Scand. 1987;222(4):361-7. doi: 10.1111/j.0954-6820.1987.tb10684.x. Acta Med Scand. 1987. PMID: 3321925 Clinical Trial.
1,045 results
Jump to page
Feedback